Information Provided By: 
Fly News Breaks for September 11, 2019
SNY, LXRX
Sep 11, 2019 | 08:13 EDT
Gabelli analyst Kevin Kedra upgraded Lexicon to Buy from Hold after the company said Sanofi (SNY) has finalized its termination of the sotagliflozin collaboration with a $260M payment, citing valuation and increased optimism for sotagliflozin's future. In a research note to investors, Kedra says the agreement is a "clean break" from Sanofi while also modestly extending Lexicon's cash runway, and expects Lexicon to have enough cash to support operations into 2021.
News For LXRX;SNY From the Last 2 Days
SNY
Apr 22, 2024 | 12:15 EDT
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here
SNY
Apr 22, 2024 | 11:36 EDT
SNY
Apr 22, 2024 | 10:33 EDT
LXRX
Apr 21, 2024 | 14:54 EDT
